Aitia

What is Aitia?

Aitia is a biotech company that harnesses Causal AI, Multi-Omics data, and Gemini Digital Twins to discover the next generation of breakthrough drugs. Their mission is to build the leading AI-enabled biotech company that accelerates the discovery and development of life-saving therapeutics to make a meaningful impact on the lives of patients. Aitia reveals the hidden biological mechanisms of disease with the power of causal AI, multi-omic patient data, and their resulting Gemini Digital Twins.

How to use Aitia?

The website provides information about Aitia’s science, partnerships, news, publications, and career opportunities. You can explore their AI-driven pipeline, learn about their team, and view their strategic partnerships. Contact information is also available on the website.

Aitia’s Core Features

Causal AI-driven drug discovery Gemini Digital Twins for disease modeling Multi-omics patient data analysis AI-driven pipeline of first-in-kind programs

Aitia’s Use Cases

• Discovering and developing new drugs for oncology and neurodegenerative diseases
• Accelerating the drug discovery process using AI
• Identifying hidden biological mechanisms of disease
• Creating digital twins of human disease from multi-omic patient data